Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Coordination Pharmaceuticals, Inc.

Clinical trials sponsored by Coordination Pharmaceuticals, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Experimental triple therapy takes on Hard-to-Treat Head-Neck cancer Results expected Sep 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Completed 1 Terminated 1

Experimental cancer combo trial ends early – only 5 patients treated

Disease control Stopped early

This early-phase trial tested a drug called RiMO-401, injected directly into tumors and followed by radiation, in people with advanced cancers that had not responded to standard treatments. Only 5 patients were enrolled before the study was terminated. The main goal was to find a…

Phase 1 • Sponsor: Coordination Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jun 26, 2026 18:38 UTC